IRCT20180923041093N3CompletedPhase 3
Efficacy of the myrtle (Myrtus Communis) syrup in the treatment of suspected novel coronavirus pneumonia (COVID-19)
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •18-65 years old
- •Developed mild to moderate COVID-19 based on Fifth Edition of the Novel Corona Virus Guidelines
- •Candidate for outpatient treatment
Exclusion Criteria
- •Allergy to myrtle
- •Asthma or allergy
- •Hypertension
- •Pregnancy/lactation
- •Congestive heart failure
- •Chronic renal failure
- •Chemotherapy
- •Taking Corticosteroid
- •Immune deficiency
Investigators
Similar Trials
Completed
Phase 3
Effect of myrtus cream on SM-induced skin pruritusCondition 1: Atopic dermatitis. Condition 2: Pruritus.Diseases of the skin and subcutaneous tissueIRCT2014090819090N1Chancellor for Research of Baqiyatallah University of Medical60
Recruiting
Early Phase 1
Evaluating the effect of Myrtus Communis cream on episiotomyIRCT20180303038932N1Shahid Beheshti University of Medical Sciences100
Completed
Phase 2
Effect of Myrtus Communis L. (Myrtle) syrup in patients with chronic rhinosinusitischronic rhinosinusitis.Other chronic sinusitis (chronic) involving more than one sinus but not pansinusitisIRCT2016020926465N1Vice Chancellor for research, Shahid Sadoughei University of Medical Sciences60
Completed
Not Applicable
Effect of Myrtus Communis in Gastro esophageal reflux diseaseGastro esophageal reflux disease.Gastro-oesophageal reflux diseaseIRCT2014102719705N1Tehran University of Medical Sciences90
Unknown
Phase 2
Comparison of Myrtus Communis L. and Descurainia Sophia L. versus salicylic acid in the treatment of wartWart.Viral wartsIRCT2012092710947N1Vice-Chancellor for Research (Tehran University of Medical Sciences)100